December 2, 2013

Melinta adds CFO

Two weeks after announcing the hire of a new chief medical officer from Shire, New Haven antibiotics maker Melinta Therapeutics has named a former Baxter International executive as CFO.

Paul Estrem most recently worked as vice president of integration at Baxter, where he oversaw the integration of the company's $4-billion acquisition of medical equipment manufacturer Gambro. He previously served as Baxter's CFO.

Melinta's is in Phase 3 studies of its investigational skin infection antibiotic, delafloxacin.

Free E-Newsletters

Sign up now for our daily and weekly
e-newsletters! Click Here

Today's Poll What is the policy on time off at your job?<>
Most Popular on Facebook
Copyright 2017 New England Business Media